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vABSTRACT
Currently, the treatment of Patent Ductus Arteriosus (PDA) by the implantation
of coronary stent has resulted in severe hemodynamic complications. There is
thus a need to customize and improve current stent geometry specific to PDA to
overcome this problem. Computational Fluid Dynamics (CFD) approaches, verified
by an experimental technique are used to analyze current stent strut configurations.
Statistical analysis is used to rank the parameter performance and to obtain the best
stent configuration. The most favorable configuration is then used to design new
stent strut configuration specific for PDA. In the analysis of the new stent design,
CFD results show low possibility of re-stenosis process due to thrombosis formation,
inflammation, and neo-intimal hyperplasia. Furthermore, comprehensive CFD analysis
by solving fluid-structure interaction (FSI) cases has produced an optimum stent strut
configuration that is structurally sound. The strength of stent strut configuration due
to hemodynamic effect is analyzed through the Von Misses stress distribution. The
results show that the new improved design of stent strut configuration has excellent
hemodynamic performance. Finally, the new stent design is predicted to be able
to overcome hemodynamic complications and stent structural failure when applied
specifically to PDA.
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ABSTRAK
Rawatan implantasi stent koronari pada Patent Ductus Arteriosus (PDA)
telah menyebabkan komplikasi hemodinamik yang ketara. Oleh yang demikian,
penambahbaikan kepada bentuk stent sedia ada perlu dilaksanakan terutamanya
untuk kegunaan PDA. Dalam kajian ini, penambahbaikan reka bentuk stent koronari
sedia ada untuk kesesuaian pemasangan di PDA telah dapat diimplementasikan.
Dinamik Bendalir Perkomputeran (CFD) turut dibuktikan dengan menggunakan
teknik eksperimen dengan menganalisis konfigurasi stent sedia ada. Analisis
statistik digunakan untuk menilai prestasi setiap parameter stent dan untuk mendapat
konfigurasi stent yang terbaik. Konfigurasi yang terbaik kemudiannya digunakan
untuk mereka bentuk konfigurasi stent yang baru khusus untuk kegunaan PDA.
Dalam analisis reka bentuk stent yang baru, hasil analisis CFD menunjukkan proses
re-stenosis yang disebabkan oleh pembentukan trombosis, keradangan, dan neo-
intimal hyperplasia adalah rendah. Selain itu, hasil analisis CFD yang menyeluruh
dengan menyelesaikan interaksi struktur-bendalir (FSI) telah membuktikan struktur
konfigurasi stent adalah kukuh. Kekuatan konfigurasi stent disebabkan oleh kesan
hemodinamik telah dikenal pasti melalui analisis agihan tegasan von Misses. Hasil
kajian menunjukkan bahawa reka bentuk stent yang diubah suai ini mempunyai
prestasi hemodinamik yang sangat baik. Akhir sekali, reka bentuk stent baru ini
dijangka dapat mengatasi komplikasi hemodinamik dan juga kegagalan struktur stent
apabila diguna pakai secara khusus dalam PDA.
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CHAPTER 1
INTRODUCTION
The implantation of thin wire meshes called stent in Ductus Arteriosus (DA)
has become a viable alternative treatment for neonates who have been diagnosed with
Cyanotic Congenital Heart Disease. The stent is temporarily implanted in the DA
region the so-called patent ductus arteriosus (PDA) within 6 to 12 months or until the
neonate has gained sufficient weight to undergo the surgical repair for palliative over
conduit surgery or first stage cavopulmonary anastomosis. Between 2001 and 2003,
approximately 8.9 percent all patients who underwent the PDA stenting procedures
were deemed unsuccessful as reported by the National Heart Institute of Malaysia
(IJN) [1]. However, rapid advancement of interventional trans-catheter stenting
technique is able to reduce mortality and morbidity in neonates [2]. From 2010 to 2011,
PDA stenting procedure were successfully implemented on 29 neonates aged less than
three months based on data reported by the Department of Pediatrics, National Heart
Institute (IJN) of Malaysia.
Maintaining the patency of DA with metallic-based coronary stent was applied
as a novel approach, but earlier results have been discouraging [1, 3, 4]. This is due
to the difficulty of pulmonary arterioplasty during definitive repairs with less than
satisfactory results when the metallic stent is densely embedded into the fibrotic tissue
[5]. The complications after the PDA invasive technique such as re-stenosis, acute
stent thrombosis, and stent embolization have inspired researchers to develop new
and improved stent technology. Previous researchers had reported that the stent strut
configurations had a major influence on the process of re-stenosis, especially on the
formation of thrombosis [5, 6, 7, 8, 9]. Thus, the stent strut configurations are required
to be studied, simulated, and analyzed in detail in order to find some degree of strut
improvement due to hemodynamic variables.
The hemodynamic stent performances are predicted based on the hemodynamic
variables via computational modeling. Recently, stented DA model can be simulated
2near the vessel environment due to the advancement and improvement of computing
ability and performance. Both computational fluid dynamic (CFD) and fluid-structure
interaction (FSI) methods are used and proven by many researchers [5, 6, 8, 9, 10] to
predict the hemodynamic stent performance of altered hemodynamic variables. Hence,
computational modeling is suitable to be utilized to predict the risk of re-stenosis based
on the hemodynamic stent impact on the arterial PDA.
This study proposes a detailed analysis and assessment via statistical data
distributions to predict the favorable hemodynamic stents performances among the
stents. Three different studies are conducted to pre-clinically assess the stent impact
on the arterial PDA stenting. This study begins by comparing the hemodynamic
variable effects on eight different types of commercial stent strut configurations.
The stents represent both open and closed cell stents implying different response in
hemodynamic variables. The hemodynamic variables considered in this study include
Time-averaged Wall Shear Stress (TAWSS), Time-averaged low Wall Shear Stress
(TAWSSlow), Time-averaged Wall Shear Stress gradient (TAWSSG), Time-averaged
Wall Shear Stress angle gradient (TAWSSAG), oscillating shear index (OSI), and
relative residence time (RRT). These hemodynamic variables are adopted to predict the
best hemodynamic stent performances through the implementation of scoring systems.
The implementation of a scoring system to determine the favorable hemodynamic stent
performances is then discussed in detail.
In the second study, modified parametric stent strut configurations are modeled
and simulated using CFD to predict the hemodynamic effects on the arterial stented
PDA. The stent modifications are made based on the hemodynamic results obtained
from the simulation of commercial stent strut configurations. The parametric stent
models differ in the number of unit cell stents, thickness, and width of strut
configurations. The hemodynamic performances of modified strut configuration are
then compared with the modified stents to find the best stent through the highest score.
In the third study, computational modelling via fluid-structure interactions
(FSI) is performed to predict the hemodynamic effect on the stented PDA. The
FSI modeling gives important information related to the stent displacement and the
maximum stress exerted on the luminal surfaces, which cannot be obtained from
rigid wall simulation. The distinctions of the luminal surface area between FSI and
rigid wall imply that the FSI method has the ability to predict nearer to the real
vessel environment as compared to rigid wall simulation. The analysis of stress
exerted on the stent surfaces is calculated through the von Misses stress that can
3predict structural stent failure due to hemodynamic effects. Thus, this study aims to
predict the hemodynamic stents performances by means of CFD and FSI to reduce the
development of re-stenosis.
1.1 Problem Statement
The increase in the rate of re-stenosis a few weeks after stent implantation was
of concern and normally depends on various factors including stent strut configurations
which alter the hemodynamic variables [5]. Four key processes can explain the process
of re-stenosis: thrombus formation, arterial inflammation, neo-intimal hyperplasia
(NIH) and remodeling [11]. These processes are triggered by the stimulus from the
injury incurred after the stenting procedure. The excessive growth of cell proliferation
from the NIH process caused blockage of the arterial wall, thus requiring another
stenting procedure. However, this subsequent stent implantation may cause a more
severe complication called in-stent restenosis.
1.2 Significance of the Study
Changes of stent strut parameters such as increasing the spacing between strut
and strut, decreasing the strut width, and sometimes fewer strut-strut intersections have
a significant effect on reducing the re-stenosis rate [12]. This may be due to a different
hemodynamic effects on blood borne and arterial wall cells after the implantation
of various stent configurations. Thus, stent geometry has become highly significant
to be studied and investigated in detail in order to improve the hemodynamic stents
performances.
1.3 Objectives
The objectives of this project are:
1. To establish the hemodynamic stent performances due to the effect of existing
strut configuration differences by altering hemodynamic variables.
42. To improve and modify stent strut configuration geometry parameterizations to
obtain desired strut configuration
3. To quantify the hemodynamic effects on the stent structural in predicting the
possibility of structural failure.
1.4 Scope
1. Stents are selected among the commercially available coronary stents.
2. The effects of hemodynamic variables in stent geometry are obtained from the
CFD and FSI only.
3. Data establishment on hemodynamic stents performances is based on simplified
DA models.
4. The experimental work is validated with the results of numerical simulation.
CHAPTER 2
LITERATURE REVIEW
2.1 The implantation of stent in Patent Ductus Arteriosus
Patent Ductus Arteriosus (PDA) stenting for newborns with cyanotic congenital
heart disease (CHD) is a minimally invasive alternative technique to surgery as shown
in Figure 2.1 [5]. This technique provides a first-stage palliation in cyanotic CHD
whereby the ductal patency becomes a sole source of pulmonary blood flow [5, 11, 12].
This procedure required the stent to be temporarily implanted between 6 months to 12
months before the patients underwent more surgical repair for palliative over conduit
surgery or first stage cavopulmonary anastomosis [2] as illustrated in Figure 2.2 [13].
This temporizing time is important for babies to survive early infancy until attaining a
sufficient weight gain before any definitive surgical can be performed [5].
In the previous research, PDA stenting has been shown to be an effective
treatment as it is performed in modified Blalock-Taussig (mBT) in promoting global
pulmonary artery growth as well as controlling the distribution of blood flow to
pulmonary artery [14]. However, keeping the ductal patency via stent until the
time of definitive repair has remained challenging in terms of long-term survival
[5] even though advanced techniques on coronary intervention for adults have been
implemented [10, 1, 15, 8]. Alwi et al, 2013 [5] reported that PDA stenting may
face a negative response from the pulmonary artery branches because of a significant
proportion of cyanotic CHD, thus the patient’s long-term survival is still undermined.
6Figure 2.1: Illustration of patent ductus arteriosus stenting for neonate with hypoplastic
left heart syndrome
Figure 2.2: Definitive repair technique implemented on cyanotic CHD; (a) Blalock -
Taussig (b) modified Blalock –Taussig (c) central shunt (d) Right ventricle-pulmonary
atresia shunt
2.2 Treatment and complications in PDA
PDA stenting is a common treatment in cyanotic CHD that provides the
bridging palliation as a first indication in order to maintain the PDA as a sole source
for pulmonary artery. The second treatment is to augment the pulmonary blood
7flow to pulmonary atresia with intact ventricular septal (PAIVS) and tricuspid atresia.
Ebstein’s anomaly is a third treatment to avoid prolonged prostaglandin E1 (PGE1)
infusion. Fourth treatment is a simple transposition of great arteries (TGA) with
inflated left ventricle. However, the American Heart Association reported PAIVS as
a first indication for PDA stenting and categorized it in class IIa while temporary
bridging palliation was categorized as class IIb, Ebstein anomaly as third indication
and finally TGA as fourth indication for PDA stenting as shown in Figure 2.3 [16].
Figure 2.3: Morphology of Congenital Heart Disease (a) PAIVS (b) Ebstein’s Anomaly
(c) TOF
Many complications have been reported after the insertion of stent such as
acute stent thrombosis, vascular injury, cardiac failure, PDA spasm, migration of the
stent, and hemorrhage [5, 6]. The failure of the palliative procedure owing to stent
stenosis from short term to medium term follow up observation has been reported
[5, 6]. However, the advances in interventional trans-catheter stenting techniques
in congenital heart has reduced the rate of mortality and morbidity in neonates [2].
Between 2001 and 2003, approximately 8.9% of patients who underwent the PDA
stenting procedure were not successful as reported by the National Heart Institute
(IJN) of Malaysia [2] because of tortuosity of PDA morphology. Previous findings
on clinical PDA stenting had shown that design of stents has influenced the process
of re-stenosis especially in formation of thrombosis [5, 6, 9, 10] as illustrated in Table
2.1. Many researchers [8, 9, 17] have concluded that the structural failure of the stent
is most apparent 2 to 5 years after clinical implantation in abdominal aortic aneurysm
and coronary arteries. No findings have reported on PDA stenting structure failure,
unless many complications are reported due to hemodynamic variables [6].
8Table 2.1: The chronology of clinical findings on PDA stenting and complications
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Schneider
et al, [10]
1998
13.3
days (d)
(median)
Coronary
stent: Pal-
maz–Schatz
stents
32 21 21 - Arterial
damage, early
re-
interventional
Gibbs et
al, [9]
1999
4-78 d Coronary
stent: Pal-
maz–Schatz
stents
- 19 17 2 died
-tortuosity
Spasm (2), stent
thrombosis
Alwi et al,
[1]2004
2.3
months
(median)
Coronary
stent
56 61 56 5 -not done
because of
tortuosity)
Stent
embolization,
Cardiac failure
Hussain et
al, [18]
2008
24 d
(mean)
Coronary
stent
14 21 14 5 - not done
because of
tortuosity),
2 died
Alwi et
al,[6]
2011
10d
(median)
Coronary
stent
37 37 37 - Acute stent
thrombosis, loss
of femoral
artery pulse (5)
Odemis et
al, [19]
2012
10.5d
(median)
Coronary
stent
8 13 9 4 2 died with
pulmonary
haemorrhage
and
retroperitoneal
haemorrhage
9Schranz et
al, [20]
2006
21 d Biodegradable
stent: (AMS,
Biotronik
TM,
Germany)
1 1 1 - -
Mc
Mahon et
al,[21]
2007
2 months Biodegradable
stent: (AMS,
Biotronik
TM,
Germany)
1 1 1 - -
2.3 Effect of stent geometry design of hemodynamics
Different designs of stents have induced the alteration of local hemodynamic
near to stent strut configurations leading to the development of re-stenosis process
[22, 23]. Maintaining unobstructed ductus arteriosus with coronary stents have been
adopted before [1, 3, 4] but early results were discouraging due to the presence of
re-stenosis [24]. Many researchers have reported that the design of the stent has
a significant influence on growth of re-stenosis even though a different material of
the stent has been used as seen in Table 2.1. Table 2.1 shows the previous studies
on the impact of stent design on arterial hemodynamic that lead to re-stenosis. Re-
stenosis is a process of re-narrowing of the stented segment of the artery because of
four key processes including thrombosis formation, arterial inflammation, neointimal
hyperplasia (NIH) and remodeling [25].
Re-stenosis in stented PDA is normally caused by divergence of local
hemodynamic near stent strut configuration leading to excessive growth of cell
proliferation associated with the embedded stent into fibrotic tissue [5]. Previous
studies reported that changes in stent design parameters such as increasing stent
connector spacing, decreasing the width of the stent strut and fewer inter-strut
connections resulted in a reduction of re-stenosis, but will increase the wall shear stress
that could cause adverse reactions to blood and arterial cells [22, 24, 25, 26, 27, 28].
The divergences of the local hemodynamic near to stent strut lead to the deposition of
platelets which finally accelerated the progression of late thrombosis [6, 22, 28, 29, 30,
31].
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Table 2.2: The stent design effect on local hemodynamic divergence that lead to re-
stenosis process
Author/Years Types Of Stents Findings
Pache et al,
2003, Mauri et
al 2008
[27, 28]
Bare Metallic
stent (BMS)
Re-stenosis is the major clinical limitation for
BMS. However, the changes in stent design:
increasing the strut-strut spacing, strut width
and fewer strut-strut interaction will reduced
the degree of stenosis.
Mauri et al
2008 [27]
Drug Eluting
Stent (DES)
Late thrombosis is the major limitation for
DES design. Long term issue compared in
BMS.
Wernick et al,
2006 [30]
DES Late thrombosis the long issues in DES
because of stent design.
Camenzind et
al, 2007 [31]
DES Stent design increased risk of late thrombosis
particularly in complex lesion subsets.
Gundert et al
2012 [22]
DES Stent strut can delayed the proses
Re-endothelialization increased the risk of
thrombosis which can lead to myocardial
infarction.
Alwi et al,
2011 [6]
Biodegradable
stent (clinical
study)
This stent has limited mechanical performance
and not strong as metallic stent which result in
early recoil and neointimal hyperplasia.
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Table 2.3: The effect on stent strut design altered hemodynamic stent performance for
both in vitro and in silico studies
Author/years Method of
study
The study aims Hemodynamic
analysis
Kono et al
(2013) [32]
Experimental
and CFD
To investigate the effect of 8
different types of the stent at
bifurcation aneurysm
WSS,
velocity, Flow
separation
Babiker et
al, 2012
[33]
Experimental
and CFD
To investigate the flow study
elucidates the influence of stent
configuration on cerebral aneurysm
fluid dynamics in an idealized
wide-neck basilar tip aneurysm
model.
Velocity
magnitude,
flow
disturbance
Gundert et
al, 2012
[22]
CFD To investigate the relationship
between vessel diameter and the
hemodynamically optimal Nc.
The area of
low time
averaged WSS
(TAWSS)
Duraiswamy
et al, 2009
[24]
CFD To investigate the characterize the
flow disturbance induced by
different commercially available
stents
WSS,
Elevated
WSS, WSSG,
Low WSS,
Flow
separation
2.4 In-vivo and In-vitro testing on stenting arteries
Clinical findings have reported that stent design plays an important role in the
formation of in stent re-stenosis and has been regarded as second risk factor in re-
stenosis process [34]. There have been reports on the different surgical outcomes in
terms of re-stenosis rate from various stent strut configurations, and these studies can
be categorized into two sections – those reporting clinical outcomes from surgery [34,
35, 36, 37, 38, 39] and those predicting the outcome of surgery through computational
means [24, 25, 26, 40] These clinical trials compared 2 stent designs throughout the
trial period with a follow up between 6 to 12 months. The stents used in these trials
were GR-II, PS, NIR, ML, SES and Bx-Velocity. The parameters of the stent design
vary and include stent strut connector spacing, opened and closed stent strut.
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The re-stenosis rate varies 0 % for SES at 6 months follow-up [41], and high
re-stenosis rate of 47.3 % was reported for GR-II at 12 months follow-up [35]. One
of the reported works concluded that strut-junction on stent design should be reduced
as the numbers contribute to stent re-stenosis [26, 39]. Kastrati et al. [34] conducted
an in vivo study of 651 patients and concluded that a reduction in strut thickness can
significantly reduce the process of re-stenosis. An in vitro study conducted by Frank
et al. [42] showed that the growth of cell and platelet adhesion was influenced by strut
spacing. This result is in agreement with those results conducted by many researchers
[37, 38, 39, 43] as illustrated in Table 2.4. Table 2.4 shows the findings on the stent
strut configurations affected the arterial hemodynamic that lead to the development of
re-stenosis process.
In 2002, Frank et al. conducted in vitro study on arterial stents [42]. The
purpose of this study was to predict both platelet adhesion and ECs re-growth under
physiological flow conditions. The typical flow chamber was developed consisting of
flat plate type, providing a varying stent strut geometry in terms of stent strut spacing
and strut height as well as protrusion into the flow stream as seen in Figure 2.4. A
transient spatially uniform velocity was imposed as the boundary inlet while zero
pressure was set up as a boundary outlet. The inlet and outlet were extended to more
than 10 times the height of the chamber to promote the developed flow. The steady
state under mean flow conditions was applied as an initial condition. Two complete
cycles of the transient flow were applied to ensure the periodicity. The results show
that the strut spacing and flow condition play important roles in the EC growth. Cell
growth was seen to be greater near the strut spacing.
Pekkan et al. [44] conducted an in vitro study on the embryonic aortic arch
using the physiological flow waveform. The aim of the study was to gain a better
biophysical understanding of fetal flow loop for flow visualization to identify the CFD
results. Both steady and unsteady circulation pump were used in this study. Left
ventricular outflow tract (LVOT) and right ventricular outflow tract (RVOT) were
investigated and measured using ultrasonic clamp-on flow probes (Model T 108,
Transonic Inc., NY). The flow visualizations on cardiac gated were then conducted
using high density prylolite particles captured by charged couple device (CCD) camera
at 250 frames/s (Model T108, Transonic Inc., NY). The results showed that distinct
swirling flow was observed for both CFD and in vitro results at pulmonary arteries
(PA) as illustrated in Figure 2.5.
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Figure 2.4: The illustration of the flow chamber with strut geometry for in vitro study
conducted by Frank et al. 2002
Figure 2.5: The experimental model conducted by Pekkan et al. 2008 on the embryonic
aortic arch model and flow visualization on mean steady flow
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Table 2.4: In vitro and in vivo findings on the effect of stent strut configurations on
arterial walls that led to the development of re-stenosis process
Author/Years Model
Type
Domain Problems Findings
Lansky et
al, 2000
[35]
Clinical Analyzed on 755 patients
with myocardial ischemia
and coronary stenoses with
stent Palmaz-Schatz and
GR-II stents
Patients treated with the
GR-II stent had more early
complications (stent
thrombosis and 30-day
composite events) and
higher late angiographic
and clinical re-stenosis rates
than did the patients treated
with the PS stent
Kastrati et
al, 2001
[34]
Clinical Analysed 4510 patients
with stent implantation
Re-stenosis appear after
coronary placement of
various stent types
Frank et al,
2002 [42]
In vitro In vitro experimental
studies of platelet adhesion
and endothelial cell
re-growth
Results from the endothelial
cell regrowth study show
that strut spacing and flow
conditions also affect the
way in which endothelial
cells regrowth over a
simulated stented artery
(images taken for 96 H of
exposure to the high flow
condition)
Briguori et
al, 2002
[45]
Analysed 821 patients
which are divided into thin
group included 400 patients
with 505 lesions and thick
group included 421 patients
with 436 lesions
Results show that strut
thickness give impact the
re-stenosis rate after stent
implantation in small
coronary arteries
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Ladisa et
al, 2005
[43]
In vitro In vitro experimental
studies of alterations in wall
shear stress predict sites of
neointimal hyperplasia
(NIH) after stent
implantation in rabbit iliac
arteries
Results show that
neointimal hyperplasia, the
spatial clustering of cells,
and expression of several
molecular mediators of
proliferation were observed
at stagnation points and in
regions of low WSS along
the cylinder
Pekkan et
al, 2008
[44]
In vitro In vitro hemodynamic
investigation of the
embryonic aortic arch at
late gestation
There were regions of
constant flow separation
distal and proximal, and
these constant separation
regions exhibited very low
platelet deposition
Larrabide
et al, 2010
[38]
In vitro Placement of a metal clip
around the neck of the
aneurysm so as to isolate
the aneurysm from the
parent vasculature and to
re-establish physiological
blood flow by method and
in vitro evaluation
Virtual angiographies are
used to compare in vitro
experiments and CFD
analysis and contrast
time-density curves for vitro
and CFD data were
generated and used to
compare them
2.5 The emerging challenges of stented arteries using computational
modelling
In silico studies via computational means have been conducted by several
researchers [23, 24, 25, 26] previously where prediction of potential re-stenosis
process has been analyzed. The emerging advanced technology of computational
modeling enable an implicit explanation of the mechanism of re-stenosis process
[12, 24, 42, 32, 46, 47, 48, 49] which is extremely difficult to obtain through
the experimental method in addition to its high cost [22, 32, 50]. Murphy et al.
[25] reported that modern computational modeling enable the accurate simulation
of models as well as the prediction of the stimuli process responsible for causing
re-stenosis after stenting. Computational modeling via computational fluid dynamic
16
(CFD) method has been evaluated to identify the effect of different stent design
configurations on the altered local hemodynamic. The hemodynamic parameters such
as velocity distribution, pressure distribution, wall shear stress (WSS) as well as wall
shear stress gradient (WSSG), oscillatory shear indices (OSI) and low WSS were
susceptible to re-stenosis [51]. The region of flow recirculation with separation and
attachment point is also susceptible to re-stenosis which is investigated with flow
separation parameter (FSP). However, Duraiswamy et al. [24] reported that the value
from FSP was too small and can be neglected.
Finite element method (FEM) is another method in computational modeling
in predicting the distribution of stress exerted along the arterial hemodynamic. This
method is able to analyze the structure behavior on stent deployment in predicting the
development of re-stenosis. Lally et al. [52] reported that the maximum principle
stress above 4MPa for the stented artery was subjected due to re-stenosis.
Advanced computational modeling has coupled two different surfaces between
intact fluid domains with elastic body to elucidate the response of stented arteries on
the compliance wall altered local hemodynamic [53, 54]. The compliance body may
influence the changes of the hemodynamic variables that represent a realistic artery
physiologically similar to real arteries.
Re-stenosis has been reported to vary in rate subjected to different stent
strut configurations [34]. Many researchers reported that various stent designs were
susceptible for re-stenosis [26, 34, 55, 56]. The formation of re-stenosis was observed
to be an obvious aggregation at a certain region in the stented artery [43]. Thus,
comprehensive knowledge of re-stenosis mechanism process after stenting is beneficial
for the future design of stent. Both qualitative and quantitative study on stented arteries
are necessary in investigating the stimuli process of tissue for re-stenosis. The findings
in these studies also are divided into two different sections; first is a study on stent
geometry and the effect of strut patterns on arterial hemodynamic and second section
investigates the effect of single stent strut configurations on arterial hemodynamic.
2.5.1 Stent geometry and strut pattern effects on arterial hemodynamic
The investigation on the impact of coronary stenting alters arterial
hemodynamic was started by Ladisa et al. 2003 by [57] using computational
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modeling via CFD method. The 3D model was modeled in straight cylindrical vessel
with commercial stent implantation resembling the Palmaz Schatz stent (Johnson &
Johnson). The un-stented coronary artery was simulated as a basis comparison. The
result findings were that WSS contributed to uniform distribution for un-stented artery
while WSS on stented artery showed non-uniform distribution. The high WSS was
seen at the surface of the stent strut which attached to the arterial wall. However, the
area of low WSS was observed to be dominated at the region near the stent strut as
illustrated in Figure 2.6. Ladisa et al. concluded that the geometry of the stent has
a significant alteration in hemodynamic especially in local WSS which increased the
risk of re-stenosis.
Figure 2.6: The contour of WSS distribution in axial plane of coronary artery
conducted by Ladisa et al. 2003
In 2004, Ladisa et al. [58] studied CFD analysis on parametric on including
Palmaz Schatz stent with variation in longitudinal cell strut, strut width and thickness
strut. The purpose of the study was to compare the hemodynamic performance of the
parametric stent strut configurations. These parametric studies varied the longitudinal
cells and strut thickness of the stent as a comparison which is illustrated in Figure 2.7.
The hemodynamic performance of stent was measured in terms of WSS distribution
exposed on the luminal surface of the stented artery. The results of the study showed
that the lower percentage of WSS distributions was exposed to the arterial wall for the
stent in fewer longitudinal cells and thinner struts. The conclusion of the study was
that the fewer the longitudinal cells and less thickness of the stent strut would reduce
the susceptible growth of the re-stenosis.
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Figure 2.7: The distribution of WSS for different design strut configurations with
straight cylindrical coronary vessel conducted by Ladisa et al. 2004
Pant et al. 2010 [26] have conducted a comparison study between five different
commercial coronary stents using CFD method. This study investigated the stent
resembling the Art stent, Bx VELOCITY stent, NIR stent, the MULTI_LINK Zeta
stent and the Biometrix stent with straight cylindrical vessel. The aim of the study
was to investigate the effect of different stent designs on the arterial hemodynamic.
Pulsatile blood flow was applied on 3D models of coronary stenting. The results
showed that the connector length in both cross–flow direction and aligned with the
main flow would affect the hemodynamic performance of stent. Design index also was
formulated in this study varying from 18.8 percent to 24.91 percent in order to quantify
the flow feature which could influence the growth of re-stenosis rates.
Similar studies by [23, 25, 32] have been reported and revealed a comparison
of the effect of various stent designs on the arterial hemodynamic. Murphy et al. [25]
compared 3 different stent designs resembling BX –Velocity stent, Gianturco-Roubin
II stent and Palmaz Schatz stent and compared re-stenosis rate from clinical outcomes
of other reported works. The statistical analysis has been performed to investigate the
hemodynamic performance of each simulated stent. Their results on coronary artery
simulation showed superior outcome for the Palmaz Schatz. In contrast, another study
compared 8 different stent designs resembling Carbosirius stent, BX-Velocity stent,
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Closed Cell S stent, Closed Cell V stent, Genesis stent, Palmaz Schatz stent, Unit Cell
stent and Type I stent on bulging shape in patent ductus arteriosus (PDA). Both closed
and opened cell stent were carried out in this study. The pusatile blood flow with
Newtonian and homogenous flow was imposed in 3D model. The aim of the study was
to compare the hemodynamic performance of the stents via hemodynamic variables
such WSS and WSSG. The results of the finding were that the Carbo Sirius stent and
BX- Velocity were found to have performed better than the rest [5]. The conclusion of
the study was that the performance of the opened cell stent was observed to be better
than closed cell stent.
2.5.2 Single stent strut configurations effect on arterial hemodynamic
Study of the impact of single stent strut configurations on the arterial
hemodynamic can predict the susceptibility of re-stenosis. Many researchers
proclaimed that the re-stenosis process was susceptible to growth near the stent strut
configurations. Thus, the study on single strut configuration was only marginally
useful in predicting the distribution of WSS in the inter strut-strut that influenced the
growth of re-stenosis.
In 2005, He et al. studied the effect of the parametric strut design over
hemodynamic variables [59]. Four different parametric models of stent strut design
were modeled in 3D as illustrated in Figure 2.8. The purpose of this study was
to compare the effect of parametric strut design on the distribution of WSS and
flow separation parameter (FSP) near stent strut configurations. The pulsatile blood
flow was imposed as a boundary condition. The results showed that stagnation flow
was observed near the stent strut design. The restoration percentage of low flow
condition on mean axial WSS was slightly lower than high flow condition with a
difference of about 10 – 12 percent. The restoration percentage of WSS for the stent
with longitudinal connectors was smaller at about 11 percent compared to without
connectors. The conclusions of the findings were that the strut design should be aligned
to the flow direction to reduce the flow recirculation and the lesser strut connector was
recommended to be parallel to the axis.
20
Figure 2.8: Parametric study on stent strut configurations conducted by He at al. 2005,
strut radius of r, axial distance between strut of h and axial strut length of f
In 2008, Balossino et al. conducted study on four different stent strut designs
including BX-Velocity stent, Jostent Flex stent, Sorin Carbostent stent and Palmaz
Schatz stent by using finite element method [60]. The expansion of each stent strut
configuration associated with normalized plaque has been analyzed numerically as
illustrated in Figure 2.9. Then, the expansion stent has been defined as a boundary
condition in CFD. The finding of the study showed the highest WSS was dominant
near the stent strut wall region throughout the cardiac cycle. The lesser stent strut
would also demonstrate the reduction in the percentages of WSSlow exposed on the
luminal surface.
Figure 2.9: Single strut configuration generated from realistic deformed CFD model
on stented coronary vessel conducted by Bolassino et al. 2008
Further study on single strut design and its effect on the arterial hemodynamic
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was conducted by Duraiswamy et al. [24] in 2009. Four different commercial design
stent struts including BX-Velocity stent, NIR stent, Wallstent stent and Aurora stent
was simulated in axial plane as shown in Figure 2.10. The objective of the finding was
to compare the flow characteristic near the stent strut using CFD method. The result of
the finding showed that the Wallstent has the worst performance of stent evaluated by
larger percentage of low mean WSS (5 dynes/cm2) and elevated WSS gradient (> 20
dyne/cm2). This finding draws the conclusion that Bx-Velocity and NIR stents were
predicted to have a lower rate of re-stenosis [8]. These results are in agreement with
the conclusion made by Salehi et al. [61] that stent similar to BX-velocity indicated
the lowest rate of re-stenosis compared to others.
Figure 2.10: Boundary condition of 3D model of single strut of BX-Velocity stent
illustrated in axial plane presented by Duraiswamy et al. 2009
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Table 2.5: Chronology studies on numerical modeling on stent design effect on the
arterial hemodynamic.
Author/Year Vessel Geometry Type of stents Modelling
Method
Hemodynamic
Variable
Investigation
Ladisa et
al, 2003
[57]
Straight cylindrical
vessel on canine left
anterior descending
coronary artery
Palmaz Schatz
stent–slotted
tube
CFD Velocity
distribution ,
Max WSS for
resting 18-65
dyne/cm2
Ladisa et
al, 2004
[58]
Straight cylindrical
vessel on canine left
anterior descending
coronary artery
Palmaz Schatz CFD WSSlow for ≤ 5
dynes/cm2
,WSSG ≤ 300
N/m3
He et al,
2005 [62]
Straight cylindrical
vessel in the
near-strut region of
stented arteries
under pulsatile flow
conditions
Palmaz Schatz
stent–slotted
tube
CFD WSSlow for ≤
0.01 dynes/cm2 ,
Mean Transverse
Shear Stress
Balossino
et al, 2008
[60]
Straight cylindrical
vessel
Palmaz
Schatz,
BX-Velocity,
Sorin
Carbostent,
and Jostent
Flex
FEM
and
CFD
WSSlow for ≤ 5
dynes/cm2
Jimenez et
al, 2009
[49]
Straight cylindrical
vessel of coronary
artery
Specific
commercial
stent with
aerodynami-
cally inspired
design
CFD Pressure field,
Shear rate
distribution and
WSS
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Pant et al,
2010 [26]
Straight cylindrical
vessel at the center
of the artery with an
axial distance of two
times artery
diameter
ART,
BX-Velocity,
NIR, MULTI-
LINK, and
Biomatrix
CFD WSSlow for ≤ 5
dynes/cm2 ,
Axial WSS for ≤
0 dynes/cm2 ,
Modified
Oscillatory Shear
Index (MOSI)
Duraiswamy
et al, 2010
[24]
Straight cylindrical
vessel on stented
arteries under
pulsatile flow
conditions
Single Unit
cell resemble
Wallstent,
BX-Velovity,
Aurora and
NIR
CFD WSSlow for ≤5
dynes/cm2 ,
WSSG for≥ 200
N/m3
Gundert et
al, 2013
[22]
Straight and rigid
cylindrical vessel
Integrity,
Driver,
Multi-Link
Vision, and
BX-Velocity
CFD WSS for ≤ 4
dynes/cm2 , Time
average WSS
(TAWSS) ,
Oscillatory Shear
Index (OSI) for >
0.1
Taib et al,
2013 [23]
Straight cylindrical
PDA vessel
Palmaz
Schatz, Type
One, Genesis,
Unit cell,
Closed Cell V,
Closed Cell S,
Cordis
BX-Velocity,
and
Carbostent
Sirius
CFD Max WSS,
WSSlow ≤ 0.5
dyne/cm2, WSSG
≤ 200 N/m3
2.6 Variables predicting the progression of vascular disease
Analysis of WSS variables would also provide the qualitative and quantitative
assessment to accurately predict the hemodynamic stent performance [63]. Stent
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strut configuration, stent geometry and stent deployment ratio were observed to have
high impact on stent hemodynamic and tissue indicator [25]. The expansion of the
stent into an intimal layer of arterial wall would influence tissue proliferation due to
hemodynamic WSS [25, 64]. The extreme growth of tissue proliferation managed
to drive the development of stenosis. Design of stent was found to have contributed
to the development of re-stenosis as reported by Kastrati et al. clinically [34]. The
abnormal hemodynamic impact on the arterial luminal surfaces has stimulated the
development of NIH through the exertion of abnormal stress on the endothelial cell
as well as increased the platelet advection and white blood cells to the arterial wall
[30]. The low WSS (WSSlow) experienced growth of thrombosis for WSS less than
0.5 N/m2 and increased the uptake the blood borne particles at the arterial wall as well
as increased the permeability of the endothelial layer [22, 25]. WSS greater than 2
N/m2 experienced reduced regulation of the molecular adhesion on the arterial wall
[65] which could lead to the formation of atherosclerosis.
Table 2.6: The prediction of re-stenosis growth through the computational analysis
Author/Years Hemodynamic variable investigation
Ladisa et al,
2003 [57]
Velocity distribution , Max WSS for resting -18-65 dyne/cm2
Ladisa et al,
2004 [58]
WSSlow for ≤ 5 dyne/cm2 ,8 dyne/cm2≤WSShigh ≤ 12
dyne/cm2, 5 dyne/cm2≤WSSmoderate≤ 8 dyne/cm2, WSSG for ≤
300 N/m3
He et al, 2005
[59]
WSSlow for ≤ 0.01 dyne/cm2and negative , Nominal Shear
Stress for 10 ± 5 dyne/cm2
Balossino et
al, 2008 [60]
WSSlow for ≤ 5 dyne/cm2
Jimenez et al,
2009 [49]
WSSlow for ≤ 5 dyne/cm2, Mean Velocity for 0.38 m/s
Pant et al,
2010 [26]
WSSlow for ≤ 5 dyne/cm2, Axial WSS for ≤ 0 dyne/cm2,
Modified Oscillatory Shear Index (MOSI) for value ‘1’ or ‘-1’
Duraiswamy
et al, 2010
[24]
WSSlow for ≤ 5 dyne/cm2, WSSG for ≥ 200 N/m3
Gundert et al,
2013 [66]
WSS for ≤ 4 dyne/cm2, Oscillatory Shear Index (OSI) for ≥ 0.1 ,
Taib et al,
2013 [23]
WSSmax for ≤ 20 dyne/cm2, WSSlow for ≤ 0.5 dyne/cm2,
WSSG for ≤ 200 N/m3, Velocity distribution, Pressure
distribution
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